Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Journal of Medicinal Chemistry|July 27, 2024
Design, Synthesis and Antitumor Activity of a Novel Class of SHP2 Allosteric Inhibitors with a Furanyl Amide-Based ScaffoldChengchun Zhu, Haiyang Zhao, Wenting Yang, et al.Die Pharmazie|April 14, 2021
Berberine prevents diabetic retinopathy through inhibiting HIF-1α /VEGF/ NF-κ B pathway in db/db miceZhujun Yin, Ruirong Tan, Tianmin Yuan, et al.Frontiers in Oncology|May 11, 2023
A deep learning model for drug screening and evaluation in bladder cancer organoidsShudi Zhang, Lu Li, Pengfei Yu, et al.Frontiers in Pharmacology|December 25, 2025
Cryptotanshinone targets tumor-immune-microbiome axis to suppress colorectal cancerZhenya Yang, Mengting Zhou, Fenglin Luo, et al.Cell Death Discovery|September 27, 2024
Organoid modeling meets cancers of female reproductive tractJiao Li, Mengting Zhou, Jun Xie, et al.Journal of Translational Medicine|March 13, 2025
IP6K2 mutations as a novel mechanism of resistance to oncolytic virus therapyZhijian Huang, Xiangqian Zhao, Zirong Jiang, et al.Chinese Medical Journal|March 4, 2025
Innovative design concepts in tumor-targeting peptide-drug conjugates: Insights into emerging applicationsRuirong Tan, Zhenya Yang, Jun Xie, et al.Food & Function|June 5, 2024
The role of tetrahydrocurcumin in disease prevention and treatmentMengting Zhou, Rui Li, Hua Hua, et al.Frontiers in Bioengineering and Biotechnology|December 20, 2024
Recent nanoengineered therapeutic advancements in sepsis managementLi Liu, Li Li, Ting Wang, et al.Cell Death & Disease|September 30, 2024
Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugatesYu-Ying Shi, Gang Fan, Ruirong Tan, et al.Pageof 4